# Ground Truth Medical Form (GTMF)

## Patient Information

- **Subject ID**: 22068
- **Admission ID**: 161143
- **Row ID**: 15599
- **Profile Type**: FULL

## Demographics

- **Age**: 71
- **Sex**: F
- **Date of Birth**: 2107-05-14
- **Ethnicity**: WHITE
- **Marital Status**: MARRIED
- **Religion**: CATHOLIC
- **Insurance**: Medicare
- **Admission Type**: EMERGENCY
- **Admission Date**: 2178-09-19 07:30:00
- **Discharge Date**: 2178-09-23 15:18:00

## Chief Complaint

abrupt onset of chest pain

## Symptoms

- **abrupt onset of chest pain** | onset: 10 p.m. on the evening prior to admission
- **stuttering chest pain postcatheterization** | onset: after catheterization
- **increased groin tenderness** | onset: evening of hospital day #2
- **constipation**
- **decreased appetite**
- **decreased p.o. intake**
- **hematoma**
- **decreased ambulation and strength**

## Medical History

Hypertension

## Allergies

NO KNOWN DRUG ALLERGIES

## Current Medications

- **Amlodipine** | dosage: 5 mg | frequency: q.d. | purpose: antihypertensive
- **Aspirin** | dosage: 325 mg | frequency: q.d. | purpose: antiplatelet

## Discharge Medications

- **Lisinopril** | dosage: 5 mg | frequency: p.o. q.d.
- **Lipitor** | dosage: 10 mg | frequency: p.o. q.d.
- **Aspirin** | dosage: 325 mg | frequency: p.o. q.d.
- **Plavix** | dosage: 75 mg | frequency: p.o. q.d.
- **Metoprolol** | dosage: 25 mg | frequency: p.o. b.i.d.
- **Nitroglycerin** | dosage: 0.3 mg | frequency: sublingual p.r.n.
- **Vitamin E** | dosage: 400 IU | frequency: p.o. q.d.

## Diagnoses

- **ST-elevation myocardial infarction (STEMI)** | notes: ST elevations in V5, V6, AVL; elevated troponin; chest pain
- **Coronary artery disease** | notes: history of hypertension, treated with stent
- **Developing groin hematoma** | notes: after catheterization, no pseudoaneurysm or fistula
- **Hypertension** | notes: past medical history
- Single-vessel (OM1) coronary artery disease status post stent placement

## Treatment Options

### Rescue angioplasty (PTCA stenting)

**Details**: Stent placed in 60% OM1 lesion

### Medication management

**Details**: Aspirin, Nitroglycerin, beta-blocker, reteplase, Captopril, Metoprolol, Lipitor, Heparin (discontinued after hematoma)

**Medications**:
- Aspirin (325 mg q.d.)
- Nitroglycerin (not provided)
- beta-blocker (not provided)
- reteplase (not provided)
- Captopril (not provided)
- Metoprolol (not provided)
- Lipitor (not provided)
- Heparin (not provided)

### Discontinuation of Heparin and pressure held

**Details**: For developing groin hematoma

### bowel regimen

**Details**: for constipation

### bedrest

**Details**: for 24 hours after hematoma

### Physical Therapy evaluation

**Details**: recommended rehabilitation stay for optimization of ambulation and strength
